The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $408,465 in first-year total cost, median $204,233.
Most frequent study sections
- Basic Mechanisms of Cancer Therapeutics Study Section[BMCT]1
- Chemo/Dietary Prevention Study Section[CDP]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- TUFTS UNIVERSITY BOSTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Inhibition of leptin-signaling axis in breast cancer by BITC1R21CA155686-01A1 | SHARMA, DIPALI | JOHNS HOPKINS UNIVERSITY, MD | $211,410 | BMCT |
| 2014 | Role of SIRT1 in Lung Cancer Prevention by Beta-Cryptoxanthin1R21CA176256-01A1 | WANG, XIANG-DONG | TUFTS UNIVERSITY BOSTON, MA | $197,055 | CDP |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.